A Study to Evaluate SAGE-217 in Participants With Parkinson’s Disease
Condition(s):Parkinson DiseaseLast Updated:November 29, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Parkinson DiseaseLast Updated:November 29, 2023Completed
Condition(s):Levodopa-induced Dyskinesia in Parkinson’s DiseaseLast Updated:February 5, 2024Recruiting
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:July 11, 2019Completed
Condition(s):Symptomatic Neurogenic Orthostatic HypotensionLast Updated:August 23, 2023Completed
Condition(s):SchizophreniaLast Updated:June 11, 2013Completed
Condition(s):Parkinson DiseaseLast Updated:February 11, 2020Completed
Condition(s):Parkinson DiseaseLast Updated:May 6, 2023Terminated
Condition(s):Parkinsonian DisordersLast Updated:August 25, 2020Completed
Condition(s):Parkinson’s DiseaseLast Updated:June 25, 2018Completed
Condition(s):Parkinson DiseaseLast Updated:March 20, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.